https://www.business-standard.com/article/companies/dr-reddy-s-launches-avigan-favipiravir-in-india-for-coronavirus-120081900659_1.html
Dr Reddy's launches Avigan (Favipiravir) in India for coronavirus | Company News - Business Standard
Dr Reddy's Laboratories Ltd announced the launch of Avigan (Favipiravir) 200 mg tablets in India
https://adisinsight.springer.com/drugsafety/803710352?error=cookies_not_supported&code=41bf8a12-1e31-49b1-9822-e5422b411f10
Favipiravir/methylprednisolone - AdisInsight
A 26-year-old woman received an off-label treatment with favipiravir and methylprednisolone for COVID-19 pneumonia.The pregnant woman was admitted to the
favipiravirmethylprednisoloneadisinsight
https://legal.economictimes.indiatimes.com/tag/favipiravir
Favipiravir - Latest favipiravir , Information & Updates - Legal -ET LegalWorld
ETLegalWorld.com brings latest favipiravir news, views and updates from all top sources for the Indian Legal industry.
latest informationfavipiravirupdateslegalet
https://adisinsight.springer.com/drugsafety/803657042?error=cookies_not_supported&code=47b49dac-71fb-414e-a1b1-28973b6c7ee3
Favipiravir - AdisInsight
A single-center retrospective cohort study involving 31 patient treated with favipiravir in Japan between February 2020 and June 2020 described two patient
favipiraviradisinsight
https://health.economictimes.indiatimes.com/news/pharma/fdc-launches-stronger-versions-of-its-generic-covid-drug-favipiravir-in-india/78962136
FDC launches stronger versions of its generic Covid drug, Favipiravir, in India, ETHealthworld
Covid Drug: These prescription-only drugs will be available at all retail medical outlets and hospital pharmacies across the country, from November 1, 2020,...
https://adisinsight.springer.com/drugsafety/803646054?error=cookies_not_supported&code=21099cb3-d6a5-41ed-9387-3fb4b1ecf651
Ciclesonide/dexamethasone/favipiravir - AdisInsight
A 77-year-old man received an off-label treatment with dexamethasone, favipiravir and ciclesonide for COVID-19 pneumonia.The man was admitted to the hospital in
dexamethasonefavipiraviradisinsight
https://health.economictimes.indiatimes.com/news/pharma/fdc-launches-2-variants-of-favipiravir-in-india-at-rs-55-per-tablet/77753584
FDC launches 2 variants of Favipiravir in India at Rs 55 per tablet, ETHealthworld
Drug firm FDC Ltd on Tuesday said it has launched two variants of the COVID-19 drug Favipiravir under the brand names PiFLU and Favenza.
https://adisinsight.springer.com/drugsafety/803601521?error=cookies_not_supported&code=ddef4c12-3e59-4084-ac05-1577795c3cdc
Favipiravir - AdisInsight
A 20-year-old man developed acute generalised exanthematous pustulosis (AGEP) following treatment with favipiravir for COVID-19 [route not stated].The man was
favipiraviradisinsight
https://cordis.europa.eu/project/id/666092/de
Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) during Ebola virus...
The ongoing Ebola outbreak in West Africa is the largest and deadliest the world has ever seen. In September 2014, the number of EBOV cases exceeded the total...
https://pubmed.ncbi.nlm.nih.gov/24084488/
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an antiviral drug that selectively inhibits the RNA-dependent RNA polymerase of influenza...
a novelviral rnafavipiravirpolymeraseinhibitor
https://economictimes.indiatimes.com/markets/stocks/news/will-the-launch-of-favipiravir-mark-the-turnaround-for-glenmark-pharma/articleshow/76498902.cms?from=mdr
favipiravir: Will the launch of Favipiravir mark the turnaround for Glenmark Pharma? - The Economic...
If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.
the launchglenmark pharmafavipiravir
https://pubmed.ncbi.nlm.nih.gov/41936427/
NMR-Based Metabolomics Profiling Reveals Dose-Dependent Cardiotoxic Effects of Favipiravir in Rats
Metabolomics is a powerful tool for assessing drug safety and understanding the biochemical effects of pharmaceutical compounds. Favipiravir, a drug widely...
https://adisinsight.springer.com/drugsafety/803605728?error=cookies_not_supported&code=c4683b1b-ddd0-436b-97ba-3c13f6613272
Favipiravir - AdisInsight
In a report of two patients, a 45-year-old man (Case 1) was described, who exhibited lack of efficacy following off-label treatment with favipiravir for
favipiraviradisinsight
https://health.economictimes.indiatimes.com/news/pharma/hyderabad-based-biophore-india-gets-dcgi-nod-to-manufacture-covid-drug-favipiravir/76959085
Hyderabad based Biophore India gets DCGI nod to manufacture COVID drug Favipiravir, ETHealthworld
Biophore India: Favipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid)...
https://health.economictimes.indiatimes.com/news/pharma/sun-pharma-latest-to-sell-covid-19-drug-favipiravir-in-india/77349874
Sun Pharma latest to sell COVID-19 drug favipiravir in India, ETHealthworld
Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in India, which saw a...
sun pharmato sell
https://special.ndtv.com/coronavirus-61/video-detail/antiviral-drug-favipiravir-effective-for-covid-19-patients-study-601992
Antiviral Drug Favipiravir Effective For Covid-19 Patients: Study
India Coming Together Against COVID-19 campaign, an RB and NDTV initiative, aims to provide a platform to highlight the works of the unsung heroes, NGOs and...
antiviraldrugfavipiravireffectivecovid